Bulltick Wealth Management, LLC Abb Vie Inc. Transaction History

Bulltick Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 24, 2024	SELL	$131.98 - $163.75 $1.26 Million - $1.56 Million	-9,557 Closed	0 $0
Q3 2021 Apr 24, 2024	BUY	$106.4 - $120.78 $32,132 - $36,475	302 Added 3.26%	9,557 $1.03 Billion
Q2 2021 Apr 24, 2024	BUY	$105.21 - $117.21 $973,718 - $1.08 Million	9,255 New	9,255 $1.04 Billion

3,841

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bulltick Wealth Management, LLC with notifications on news.